| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |